Alex Harding
Corporate Officer/Principal at CRISPR THERAPEUTICS AG
Profile
Alex Harding is currently the Head of Business Development and Senior Vice President at CRISPR Therapeutics AG since 2023.
Prior to this, he worked as an Associate at Atlas Venture Advisors, Inc. from 2018 to 2019.
He also held the position of Senior Vice President of Business Development at Remix Therapeutics, Inc. Dr. Harding completed his Doctorate degree from The Johns Hopkins University in 2015, his Undergraduate degree from Yale University in 2014, and his MBA from Harvard Business School in 2014.
Alex Harding active positions
Companies | Position | Start |
---|---|---|
CRISPR THERAPEUTICS AG | Corporate Officer/Principal | 2023-01-04 |
Former positions of Alex Harding
Companies | Position | End |
---|---|---|
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Analyst | 2019-12-30 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Training of Alex Harding
The Johns Hopkins University | Doctorate Degree |
Yale University | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CRISPR THERAPEUTICS AG | Health Technology |
Private companies | 2 |
---|---|
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Alex Harding